JP2011513340A - 腫瘍の予防または治療用医薬の製造における茶ポリフェノールの使用 - Google Patents

腫瘍の予防または治療用医薬の製造における茶ポリフェノールの使用 Download PDF

Info

Publication number
JP2011513340A
JP2011513340A JP2010549002A JP2010549002A JP2011513340A JP 2011513340 A JP2011513340 A JP 2011513340A JP 2010549002 A JP2010549002 A JP 2010549002A JP 2010549002 A JP2010549002 A JP 2010549002A JP 2011513340 A JP2011513340 A JP 2011513340A
Authority
JP
Japan
Prior art keywords
use according
tea polyphenol
tea
epigallocatechin
gallate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010549002A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011513340A5 (enExample
Inventor
莉 張
蘊華 劉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JP2011513340A publication Critical patent/JP2011513340A/ja
Publication of JP2011513340A5 publication Critical patent/JP2011513340A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
JP2010549002A 2008-03-06 2009-03-05 腫瘍の予防または治療用医薬の製造における茶ポリフェノールの使用 Pending JP2011513340A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN200810034350A CN101524348A (zh) 2008-03-06 2008-03-06 茶多酚在制备治疗肿瘤药剂中的应用
PCT/CN2009/000233 WO2009109109A1 (zh) 2008-03-06 2009-03-05 茶多酚在制备预防或治疗肿瘤药物中的应用

Publications (2)

Publication Number Publication Date
JP2011513340A true JP2011513340A (ja) 2011-04-28
JP2011513340A5 JP2011513340A5 (enExample) 2012-04-12

Family

ID=41055542

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010549002A Pending JP2011513340A (ja) 2008-03-06 2009-03-05 腫瘍の予防または治療用医薬の製造における茶ポリフェノールの使用

Country Status (5)

Country Link
US (1) US20110021620A1 (enExample)
EP (1) EP2263668B1 (enExample)
JP (1) JP2011513340A (enExample)
CN (2) CN101524348A (enExample)
WO (1) WO2009109109A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016104429A1 (ja) * 2014-12-22 2016-06-30 シーシーアイ株式会社 癌細胞増殖抑制組成物および癌細胞増殖の抑制方法

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102580112A (zh) * 2012-02-28 2012-07-18 南京农业大学 Egcg磷脂复合物的制备方法
CN104957034B (zh) * 2015-07-15 2016-06-08 福建农林大学 一种抑瘤功能茶树良种的选育方法
US10380765B2 (en) * 2016-08-17 2019-08-13 Magna Electronics Inc. Vehicle vision system with camera calibration
CN107115337A (zh) * 2017-07-06 2017-09-01 中国科学院上海有机化学研究所 一种儿茶素类化合物的应用
CN111944771B (zh) * 2019-10-29 2022-06-14 华南农业大学 茶多酚或其组分在制备粪肠球菌噬菌体钝化剂中的应用
CN115887443A (zh) * 2023-02-27 2023-04-04 深圳市第二人民医院(深圳市转化医学研究院) 表没食子儿茶素在制备结直肠癌治疗药物中的应用
CN119386097A (zh) * 2024-10-31 2025-02-07 重庆市优胜科技发展有限公司 茶多酚在防治三阴性乳腺癌中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6410052B1 (en) * 1999-03-30 2002-06-25 Purdue Research Foundation Tea catechins in sustained release formulations as cancer specific proliferation inhibitors
US6428818B1 (en) * 1999-03-30 2002-08-06 Purdue Research Foundation Tea catechin formulations and processes for making same
JP3525182B2 (ja) * 2000-02-16 2004-05-10 独立行政法人産業技術総合研究所 新規抗白血病細胞剤
US7192612B2 (en) * 2001-02-22 2007-03-20 Purdue Research Foundation Compositions and methods based on synergies between capsicum extracts and tea catechins for prevention and treatment of cancer
JP2005075790A (ja) * 2003-09-02 2005-03-24 Fumio Hashimoto Ａｐｏｐｔｏｓｉｓ誘導剤

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
JPN6013043083; ＭＯＲＲＥ，　Ｄ．Ｊ．　ｅｔ　ａｌ．: Ｐｈａｒｍａｃｏｌｏｇｙ　＆　Ｔｏｘｉｃｏｌｏｇｙ Ｖｏｌ．９２, 2003, ｐ．２３４-２４１ *
JPN6013043085; ＺＨＡＯ，　Ｙ．　ｅｔ　ａｌ．: Ｃａｎｃｅｒ　Ｌｅｔｔｅｒｓ Ｖｏｌ．１２１, 1997, ｐ．１６３-１６７ *
JPN6013043088; ＬＩ，　Ｈ．　ｅｔ　ａｌ．: Ｊｐｎ．　Ｊ．　Ｃａｎｃｅｒ　Ｒｅｓ． Ｖｏｌ．９１, 2000, ｐ．３４-４０ *
JPN6013043089; ＮＡＫＡＺＡＴＯ，　Ｔ．　ｅｔ　ａｌ．: Ｃｌｉｎ　Ｃａｎｃｅｒ　Ｒｅｓ Ｖｏｌ．１１，　Ｎｏ．１６, 2005, ｐ．６０４０-６０４９ *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016104429A1 (ja) * 2014-12-22 2016-06-30 シーシーアイ株式会社 癌細胞増殖抑制組成物および癌細胞増殖の抑制方法
JPWO2016104429A1 (ja) * 2014-12-22 2017-09-28 シーシーアイ株式会社 癌細胞増殖抑制組成物および癌細胞増殖の抑制方法

Also Published As

Publication number Publication date
WO2009109109A1 (zh) 2009-09-11
CN101524348A (zh) 2009-09-09
EP2263668B1 (en) 2014-05-14
CN101965185A (zh) 2011-02-02
EP2263668A1 (en) 2010-12-22
US20110021620A1 (en) 2011-01-27
EP2263668A4 (en) 2012-05-09

Similar Documents

Publication Publication Date Title
JP2011513340A (ja) 腫瘍の予防または治療用医薬の製造における茶ポリフェノールの使用
Mawalizadeh et al. Quercetin potentiates the chemosensitivity of MCF-7 breast cancer cells to 5-fluorouracil
US11020372B2 (en) Dietary and natural product management of negative side effects of cancer treatment
KR101977840B1 (ko) 백혈병 치료용 약학 조성물 및 그 제조 방법
CN102552908B (zh) 含青蒿素及青蒿素类衍生物和Bcl-2抑制剂的药物组合物及其应用
Das et al. Quercetin and 5-Fu loaded chitosan nanoparticles trigger cell-cycle arrest and induce apoptosis in HCT116 cells via modulation of the p53/p21 axis
CN102688493B (zh) 含有白藜芦醇及白藜芦醇类衍生物和Bc1-2抑制剂的药物组合物及其应用
CN102441168B (zh) 含芹菜素及芹菜素类衍生物和Bcl-2抑制剂的药物组合物及其在制备治疗癌症的药物中的应用
CN102166260B (zh) 具有抗肿瘤作用的丁香提取物及其药物制剂
CN107375258A (zh) 一种抗肿瘤联合用药物及其在制备抗癌药物中的用途
Mehta et al. Anti-cancer Properties of Dietary Supplement CELNORM against Colon and Lung Cancer: An in vitro preliminary study
CN112089710A (zh) 4-羟基异亮氨酸在制备抗肿瘤药物中的应用
US9943560B2 (en) Medical compositions containing liquorice extracts with synergistic effect
CN102526024B (zh) 一种抗癌药物组合物
CN104398517A (zh) 乙胺嘧啶的新用途及治疗肿瘤的药物组合物
US20130303604A1 (en) Method of Using Tea Polyphenols for Prevention and Treatment of Malignant Tumors in a Hematopoietic System
ES2275647T3 (es) Diantraquinonas policiclicas como agentes anti-cancerosos y anti-angiogenicos.
CN103565849B (zh) 一种含螺旋藻的胶囊及其制备方法
CN108096239B (zh) 一种治疗脑胶质瘤和肝癌的药物组合物
CN111249274A (zh) 银杏内酯b在制备胶质瘤细胞活性抑制剂中的应用
WO2020199973A1 (zh) A-失碳-5α雄甾烷化合物类药物与抗癌药物的联合应用
CN110063988A (zh) 一种治疗神经母细胞瘤的药物组合物及其制备方法
CN110151824A (zh) 一种治疗下咽癌的药物组合物及其制备方法
CN102526033B (zh) 由表没食子儿茶素没食子酸酯与丝裂霉素c制成的抑制肿瘤细胞增殖的组合物
CN102526081A (zh) 一种抑制肿瘤细胞增殖的药物组合物

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120222

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20120223

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130903

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20131202

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20131209

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20140311